2021 Q1 Form 10-Q Financial Statement
#000143774921013178 Filed on May 24, 2021
Income Statement
Concept | 2021 Q1 |
---|---|
Revenue | $390.0K |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | $224.8K |
YoY Change | |
% of Gross Profit | |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $297.0K |
YoY Change | |
% of Gross Profit | |
Operating Expenses | $1.727M |
YoY Change | |
Operating Profit | $4.421M |
YoY Change | |
Interest Expense | $459.0K |
YoY Change | |
% of Operating Profit | 10.38% |
Other Income/Expense, Net | |
YoY Change | |
Pretax Income | $4.430M |
YoY Change | |
Income Tax | |
% Of Pretax Income | |
Net Earnings | -$2.046M |
YoY Change | |
Net Earnings / Revenue | -524.62% |
Basic Earnings Per Share | $0.00 |
Diluted Earnings Per Share | $0.00 |
COMMON SHARES | |
Basic Shares Outstanding | 0.000 |
Diluted Shares Outstanding | 0.000 |
Balance Sheet
Concept | 2021 Q1 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $139.6M |
YoY Change | |
Cash & Equivalents | $23.39M |
Short-Term Investments | $138.7M |
Other Short-Term Assets | $391.7K |
YoY Change | |
Inventory | |
Prepaid Expenses | $391.7K |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $140.0M |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | -$1.00 |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $140.0M |
Total Long-Term Assets | -$1.00 |
Total Assets | $140.0M |
YoY Change | |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $125.6K |
YoY Change | |
Accrued Expenses | |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $0.00 |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $4.885M |
YoY Change | |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | $13.36M |
YoY Change | |
Total Long-Term Liabilities | $13.36M |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $4.885M |
Total Long-Term Liabilities | $13.36M |
Total Liabilities | $18.24M |
YoY Change | |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$16.95M |
YoY Change | |
Common Stock | |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$16.95M |
YoY Change | |
Total Liabilities & Shareholders Equity | $140.0M |
YoY Change |
Cashflow Statement
Concept | 2021 Q1 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$2.046M |
YoY Change | |
Depreciation, Depletion And Amortization | $297.0K |
YoY Change | |
Cash From Operating Activities | -$1.272M |
YoY Change | |
INVESTING ACTIVITIES | |
Capital Expenditures | $10.00K |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | -$17.34K |
YoY Change | |
Cash From Investing Activities | -$1.273M |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | $25.86M |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | -$1.272M |
Cash From Investing Activities | -$1.273M |
Cash From Financing Activities | $25.86M |
Net Change In Cash | $23.32M |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | -$1.272M |
Capital Expenditures | $10.00K |
Free Cash Flow | -$1.282M |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001823587 | |
CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2021Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Yellowstone Acquisition Co | |
CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2021Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021Q1 | dei |
Security12b Title
Security12bTitle
|
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant | |
CY2021Q1 | dei |
Trading Symbol
TradingSymbol
|
ysac | |
CY2021Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
125629 | |
CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
153928 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
||
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
||
CY2021Q1 | us-gaap |
Assets
Assets
|
139997369 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
140241606 | |
CY2021Q1 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
138730613 | |
CY2020Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
138716226 | |
CY2021Q1 | us-gaap |
Cash
Cash
|
875049 | |
CY2020Q4 | us-gaap |
Cash
Cash
|
1122194 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1122194 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
875049 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-247145 | |
CY2021Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4646151 | |
CY2021Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed the Federal Depository Insurance Coverage of <div style="display: inline; font-style: italic; font: inherit;">$250,000.</div> At <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced losses on these accounts and management believes the Company is <div style="display: inline; font-style: italic; font: inherit;">not</div> exposed to significant risks on such accounts.</div></div></div></div></div></div> | |
CY2021Q1 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
13357690 | |
CY2020Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
18003841 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
73569 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4430213 | |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
CY2021Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
||
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-28299 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-11479 | |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
||
CY2021Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
11813 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
18242934 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
22917384 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
139997369 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
140241606 | |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4885244 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4913543 | |
CY2021Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-2948 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-17335 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-229810 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4430213 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
4421348 | |
CY2021Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
416180678 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
391707 | |
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
403186 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
416163343 | |
CY2021Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
101234 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-16954665 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-21384878 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-16954325 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21384538 | |
CY2020Q4 | ysac |
Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
|
10.20 | |
ysac |
Maximum Dissolution Expenses Failure To Complete Business Combination
MaximumDissolutionExpensesFailureToCompleteBusinessCombination
|
100000 | ||
CY2021Q1 | ysac |
Percentage Of Shares Mandatorily Redeemed If Fail To Complete Business Combination
PercentageOfSharesMandatorilyRedeemedIfFailToCompleteBusinessCombination
|
1 | |
CY2021Q1 | us-gaap |
Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
|
50000 | |
CY2021Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div> | |
CY2021Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | |
CY2021Q1 | ysac |
Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
|
0.5 | |
ysac |
Business Combination Period From Ipo For Mandatory Combination
BusinessCombinationPeriodFromIpoForMandatoryCombination
|
P1Y90D | ||
CY2021Q1 | ysac |
Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
|
0.8 | |
CY2021Q1 | ysac |
Business Combination Required Net Tangible Assets
BusinessCombinationRequiredNetTangibleAssets
|
5000001 | |
CY2021Q1 | ysac |
Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
|
1 | |
CY2021Q1 | ysac |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
4759615 | |
CY2020Q4 | ysac |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
4759615 | |
CY2021Q1 | ysac |
Stock Redeemed Maximum Percentage Of Outstanding Shares
StockRedeemedMaximumPercentageOfOutstandingShares
|
0.15 | |
CY2021Q1 | ysac |
Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
|
2500000 | |
CY2021Q1 | ysac |
Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
|
4759615 | |
CY2021Q1 | ysac |
Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
|
0.20 | |
CY2021Q1 | ysac |
Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
|
0.35 |